-Treatment

En février 2017, le Programme Nationale pour la Lutte contre le Sida en Côte d’Ivoire (PNLS CI) a émis une note circulaire aux prestataires de santé pour annoncer l’adoption de l’approche "Tester et traiter tous" comme nouvelle stratégie de prise en charge des personnes vivant avec le VIH en Côte d’Ivoire.

These videos were created as part of the "Life is Precious, Take Care of It" campaign supported by Breakthrough ACTION Zambia. The videos feature three HIV positive men who tell their stories and explain how they live in good health and strength due to carefully adhereing to their ART regimens. They also remind men to get tested for HIV so that they know their status and to use condoms everey time they have sex.

These posters, part of the Breakthrough ACTION project in Zambia, show healthy, strong men who have been on ARV medications for years, performing hard work, and looking well.  They are part of the "Know Your Status. Get Tested. Get Treated!" campaign.

In collaboration with the National AIDS Control Programme, Breakthrough ACTION launched a campaign in March 2020 in the fight against HIV in Côte d’Ivoire. The campaign is intended to improve retention in 31 high-volume priority care sites for people living with HIV in Abidjan.

Frères Pour la Vie (FPV) est un programme parrainé par l'USAID qui vise à accroître l'engagement dans le continuum des soins du VIH pour les hommes en Côte d'Ivoire. Le programme FPV Côte d'Ivoire est mis en oeuvre par le Centre des programmes de communication (CCP) - Bureau de Côte d'Ivoire en partenariat avec les organisations non gouvernementales (ONG) de prestation de services locales.

Brothers for Life (BFL) is a USAID-sponsored program designed to increase engagement in the HIV care continuum for men in Côte d’Ivoire. BFL Côte d’Ivoire is being implemented by the JHU Center for Communication Programs (CCP)–Côte d’Ivoire Office in partnership with local service delivery non-governmental organizations (NGOs). 

In 2016, Solidarity and Action Against the HIV Infection in India began a partnership with Janssen Global Public Health, an initiative of the Janssen Pharmaceutical Companies of Johnson & Johnson. The initiative, named m-Maitri, aimed to complement on-the-ground efforts at ensuring retention in the prevention of parent-to-child transmission cascade with interactive voice response (IVR) to consenting pregnant women and mother-baby pairs until the babies reach 18 months of age.

Pages